← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Clear Scientific, Llc
Cambridge, MA
$36,499,901
Total funding
8
Grants
Funding over time
peak $8.6M · FY2020–25$10M$7.5M$5M$2.5M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$36,499,901 · 8
By mechanism
U01$24,018,898 · 2
UG3$6,087,655 · 1
R44$5,528,818 · 2
R43$864,530 · 3
Investigators at Clear Scientific, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication$4,092,920
U01 · FY2024 · DA
Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication$4,069,920
U01 · FY2023 · DA
Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication$4,067,228
U01 · FY2022 · DA
Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication$3,941,786
U01 · FY2021 · DA
Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication$3,932,236
U01 · FY2020 · DA
Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication$3,799,875
U01 · FY2025 · DA
A Therapeutic Agent to Lower the Level of Synthetic Opioids in the Body$3,051,790
UG3 · FY2024 · DA
A Therapeutic Agent to Lower the Level of Synthetic Opioids in the Body$3,035,865
UG3 · FY2023 · DA
A Novel Reversal Agent for Treatment of Overdose from the Combination of Fentanyl and Xylazine$1,536,796
R44 · FY2025 · DA
A Novel Reversal Agent for Treatment of Overdose from the Combination of Fentanyl and Xylazine$1,462,687
R44 · FY2024 · DA
Novel Therapeutic Agents to Reverse Opioid Overdose$1,283,728
R44 · FY2021 · DA
Novel Therapeutic Agents to Reverse Opioid Overdose$1,245,607
R44 · FY2022 · DA
An oral therapeutic to treat intoxication by prescription and illicit stimulants$319,946
R43 · FY2022 · DA
A novel therapeutic approach for treatment of acute intoxication by co-use of opioids and stimulants$319,695
R43 · FY2022 · DA
Novel Therapeutic Agents to Reverse Opioid Overdose$224,889
R43 · FY2020 · DA
Evaluation of the drug-drug interactions of fentanyl with stimulants in the context of overdose$114,933
U01 · FY2021 · DA